Melanoma-Specific Mortality in Patients with Pre-Transplant Melanoma

Authors

X. Hao, National Cancer Institute, Bethesda, MD
F. Zwald, Skin Cancer Surgery Center, Atlanta, GA
K. Yu, National Cancer Institute, Bethesda, MD
A. Austin, New York State Cancer Registry, Albany, NY
Mei Chin Hsieh, LSU Health Sciences Center - New OrleansFollow
K. Pawlish, New Jersey Department of Health, Trenton, NJ
J. Li, New Jersey Department of Health, Trenton, NJ
C. Lynch, The University of Iowa, Iowa City
M. Sargen, National Cancer Institute, Bethesda, MD
E. Engels, National Cancer Institute, Bethesda, MD

Document Type

Conference Proceeding

Publication Date

5-31-2023

Publication Title

American Journal of Transplantation

Abstract

American Transplant Congress 2023, July 3 - 7, 2023, San Diego, CA

First Page

S1197

Last Page

S1198

Volume

23

Issue

6 Supplement 1

Comments

Abstract #D316

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Hao, X.; Zwald, F.; Yu, K.; Austin, A.; Hsieh, Mei Chin; Pawlish, K.; Li, J.; Lynch, C.; Sargen, M.; and Engels, E., "Melanoma-Specific Mortality in Patients with Pre-Transplant Melanoma" (2023). School of Public Health Faculty Publications. 372.
https://digitalscholar.lsuhsc.edu/soph_facpubs/372
10.1016/j.ajt.2023.05.014